Literature DB >> 1596200

Sleep disturbance, depression, and lesion site in patients with multiple sclerosis.

C M Clark1, J A Fleming, D Li, J Oger, H Klonoff, D Paty.   

Abstract

We examined the prevalence of sleep problems in a sample of patients with mild but clinically definite multiple sclerosis (n = 143) and sought to determine whether there was a relationship between the presence of sleep complaints and the level of depression. As magnetic resonance imaging scans were available for a subsample of the patients with multiple sclerosis (n = 117), we also wanted to determine whether there was a relationship between the site of the lesion and the presence of sleep difficulties. The prevalence of sleep difficulties was three times higher in the patients with multiple sclerosis than the control group (25.2% vs 8.2%). Moreover, the presence of sleep complaints was associated with higher levels of depression. Three lesion sites that subserve supplemental motor areas were significantly related to the presence of sleep complaints. These findings suggest that, for some patients with MS, sleep disturbance and accompanying increases in depression may be a function of the lesion site resulting in nocturnal spasms.

Entities:  

Mesh:

Year:  1992        PMID: 1596200     DOI: 10.1001/archneur.1992.00530300077013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  21 in total

1.  Effect of eszopiclone on sleep disturbances and daytime fatigue in multiple sclerosis patients.

Authors:  Hrayr Attarian; Garrick Applebee; Angela Applebee; Bingxia Wang; Melissa Clark; Becky McCormick; Emma Salzman; Catherine Schuman
Journal:  Int J MS Care       Date:  2011

2.  Effect of a Single Bout of Intermittent versus Continuous Walking on Perceptions of Fatigue in People with Multiple Sclerosis.

Authors:  Herb Karpatkin; Adam Rzetelny
Journal:  Int J MS Care       Date:  2012

3.  Identification of Beck Depression Inventory items related to multiple sclerosis.

Authors:  D C Mohr; D E Goodkin; W Likosky; L Beutler; N Gatto; M K Langan
Journal:  J Behav Med       Date:  1997-08

4.  Unrecognised symptoms of depression in a community-based population with multiple sclerosis.

Authors:  C McGuigan; M Hutchinson
Journal:  J Neurol       Date:  2005-09-27       Impact factor: 4.849

5.  Symptomatic therapy in multiple sclerosis.

Authors:  Teresa C Frohman; Wanda Castro; Anjali Shah; Ardith Courtney; Jeffrey Ortstadt; Scott L Davis; Diana Logan; Thomas Abraham; Jaspreet Abraham; Gina Remington; Katherine Treadaway; Donna Graves; John Hart; Olaf Stuve; Gary Lemack; Benjamin Greenberg; Elliot M Frohman
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

6.  Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis.

Authors:  M J Taphoorn; E van Someren; F J Snoek; R L Strijers; D F Swaab; F Visscher; L P de Waal; C H Polman
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

Review 7.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

8.  Prevalence of sleep problems in individuals with multiple sclerosis.

Authors:  A M Bamer; K L Johnson; D Amtmann; G H Kraft
Journal:  Mult Scler       Date:  2008-07-16       Impact factor: 6.312

9.  Failure of physician documentation of sleep complaints in hospitalized patients.

Authors:  H H Meissner; A Riemer; S M Santiago; M Stein; M D Goldman; A J Williams
Journal:  West J Med       Date:  1998-09

10.  The impact of disability, fatigue and sleep quality on the quality of life in multiple sclerosis.

Authors:  Haleh Ghaem; Afshin Borhani Haghighi
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.